CORESTEMCHEMON Inc. (KOSDAQ:166480)
South Korea · Delayed Price · Currency is KRW 2,410.00
-120.00 (-4.74%)
At close: Apr 2, 2026
CORESTEMCHEMON Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 20,159 | 28,762 | 33,657 | 45,878 | 30,240 |
Other Revenue | 0 | 0 | - | - | - |
| 20,159 | 28,762 | 33,657 | 45,878 | 30,240 | |
Revenue Growth (YoY) | -29.91% | -14.54% | -26.64% | 51.71% | 14.73% |
Cost of Revenue | 24,305 | 29,969 | 30,246 | 30,729 | 22,254 |
Gross Profit | -4,146 | -1,207 | 3,411 | 15,149 | 7,986 |
Selling, General & Admin | 9,493 | 7,777 | 8,060 | 8,059 | 5,667 |
Research & Development | 7,187 | 12,682 | 12,763 | 11,385 | 12,131 |
Amortization of Goodwill & Intangibles | 49.54 | 54.64 | 192.05 | 297.03 | 306.12 |
Other Operating Expenses | 32.03 | 20.75 | 190.98 | 101.7 | 66.22 |
Operating Expenses | 17,121 | 20,812 | 23,124 | 21,501 | 18,536 |
Operating Income | -21,267 | -22,019 | -19,713 | -6,352 | -10,550 |
Interest Expense | -1,685 | -4,488 | -3,759 | -5,463 | -5,071 |
Interest & Investment Income | 202.55 | 215.34 | 325.81 | 1,034 | 763.87 |
Currency Exchange Gain (Loss) | 1.79 | 16.21 | -3 | 799.46 | 337.85 |
Other Non Operating Income (Expenses) | 454.51 | -6,853 | 7,695 | 14,853 | 9,703 |
EBT Excluding Unusual Items | -22,294 | -33,128 | -15,454 | 4,870 | -4,816 |
Impairment of Goodwill | -3,950 | - | - | - | - |
Gain (Loss) on Sale of Investments | 51.42 | 136.94 | -81.57 | 159.69 | 391.17 |
Gain (Loss) on Sale of Assets | 774.84 | -0.05 | -244.33 | -5.28 | -0.17 |
Other Unusual Items | -1,376 | 1,688 | -1,896 | -1,618 | - |
Pretax Income | -26,793 | -31,303 | -17,676 | 3,407 | -4,425 |
Income Tax Expense | 40.05 | -5,051 | -4.5 | 2,704 | 571.2 |
Earnings From Continuing Operations | -26,833 | -26,252 | -17,672 | 702.26 | -4,996 |
Minority Interest in Earnings | - | - | - | -2,959 | -2,003 |
Net Income | -26,833 | -26,252 | -17,672 | -2,257 | -6,999 |
Net Income to Common | -26,833 | -26,252 | -17,672 | -2,257 | -6,999 |
Shares Outstanding (Basic) | 30 | 23 | 21 | 16 | 16 |
Shares Outstanding (Diluted) | 30 | 23 | 25 | 18 | 18 |
Shares Change (YoY) | 27.23% | -5.68% | 37.33% | -0.13% | 14.87% |
EPS (Basic) | -903.00 | -1124.00 | -824.79 | -139.95 | -443.77 |
EPS (Diluted) | -903.00 | -1124.00 | -837.00 | -533.10 | -642.51 |
Free Cash Flow | -15,922 | -43,824 | -24,870 | -17,351 | -22,690 |
Free Cash Flow Per Share | -535.82 | -1876.32 | -1004.33 | -962.25 | -1256.73 |
Gross Margin | -20.57% | -4.20% | 10.13% | 33.02% | 26.41% |
Operating Margin | -105.50% | -76.56% | -58.57% | -13.85% | -34.89% |
Profit Margin | -133.11% | -91.27% | -52.51% | -4.92% | -23.14% |
Free Cash Flow Margin | -78.98% | -152.36% | -73.89% | -37.82% | -75.03% |
EBITDA | -17,110 | -17,239 | -14,826 | -1,762 | -6,664 |
EBITDA Margin | -84.87% | -59.94% | -44.05% | -3.84% | -22.04% |
D&A For EBITDA | 4,158 | 4,780 | 4,887 | 4,590 | 3,886 |
EBIT | -21,267 | -22,019 | -19,713 | -6,352 | -10,550 |
EBIT Margin | -105.50% | -76.55% | -58.57% | -13.85% | -34.89% |
Effective Tax Rate | - | - | - | 79.39% | - |
Advertising Expenses | 288.48 | 131.69 | 248.95 | 85.13 | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.